Factor V
F5proteinFactor V acts as a cofactor in the prothrombinase complex to amplify thrombin generation and drive fibrin polymerization during coronary thrombus formation.
Pathway placement
Cascade stepCoagulation & thrombus formation
Confidencehigh
RationaleCoagulation cofactor essential for thrombin generation; activated on platelet surface; directly participates in fibrin formation.
Also acts inPlatelet activation
Druggability
DruggableYes
Known drugs / candidates1
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000198734
Type I vs Type II discrimination
ScoresType-II-associated
R — rupture / Type-I—
C — confounder / Type-II89
A — assay feasibility72
E — evidence strength45
T1DI (composite)4
Specificity differential (R−C)-73.9
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
3hypovolemia / dehydrationn/a
4tachyarrhythmian/a
5hypoxemia / respiratory failuremag 3
6hypertensive emergencyn/a
7high-demand / peri-operative stressmag 3
Coverage: 3/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 3 supporting references. See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(11)
- Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease.Frontiers in cardiovascular medicine · 2020 · PMID 32671099 · doi
- Prevalence of thrombophilic disorders in takotsubo patients: the (ThROmbophylia in TAkotsubo cardiomyopathy) TROTA study.Clinical research in cardiology : official journal of the German Cardiac Society · 2016 · PMID 27003690 · doi
- Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment.Journal of affective disorders · 2014 · PMID 24679387 · doi
- Prothrombotic gene polymorphisms and plasma factors in young North Indian survivors of acute myocardial infarction.Journal of thrombosis and thrombolysis · 2012 · PMID 22535530 · doi
- Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.American journal of human genetics · 2012 · PMID 22703881 · doi
- Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.American journal of hematology · 2009 · PMID 19105233 · doi
- Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.Journal of biological regulators and homeostatic agents · 2004 · PMID 15471223
- Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction.Acta cardiologica · 2001 · PMID 11315119 · doi
- Prothrombotic genetic risk factors in young survivors of myocardial infarction.Blood · 1999 · PMID 10381497
- Rebound after cessation of oral anticoagulant therapy: the biochemical evidence.British journal of haematology · 1996 · PMID 8603020 · doi
- Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers.Thrombosis research · 1994 · PMID 7863479 · doi